Zealand Pharma - Transactions related to share buy-back program (week 24, 2026)

Zealand Pharma completed 258,000 share repurchases during week 24 (June 8-12, 2026) at an average price of DKK 276.72 per share, totaling DKK 71.1 million. The company has now accumulated 1,009,000 shares under its DKK 1.3 billion buy-back program, representing approximately 2.63% of share capital. The program, managed by Danske Bank, is scheduled for completion by October 31, 2026.